Navigation Links
Expand High Fidelity PCR System

for one-step RT-PCR amplification of up to 3 kb RNA targets

Cat. No. 1 732 641 100 units
Cat. No. 1 732 650 500 units
Cat. No. 1 759 078 2500 units Description Unique enzyme blend of Taq and Pwo DNA Polymerases. The Expand High Fidelity PCR System also includes:
  • Expand High Fidelity buffer, 10x conc., with 15 mM MgCl2
  • Expand High Fidelity buffer, 10x conc., without MgCl2
  • MgCl2 stock solution, 25 mM
Application

Expand High Fidelity PCR System is an unique enzyme blend (Taq / Pwo DNA polymerase) that is ideal for amplifying fragments up to 5 kb from human genomic DNA. It gives better results (higher yield and greater fidelity) than Taq DNA Polymerase alone in standard PCR reactions. (See also "How the Expand High Fidelity PCR System Outperforms Taq DNA Polymerase").

Note: If Expand Reverse Transcriptase (Cat. No. 1785826)a, AMV Reverse Transcriptase (Cat. No. 1495062), or the First Strand cDNA Synthesis for RT-PCR (Cat. No. 1483188) is used for cDNA synthesis in a two step RT-PCR, RNA templates with a length up to 5 kb can be amplified. Expand Reverse Transcriptase is a genetically engineered version of M-MuLV Reverse Transcriptase. A point mutation within the RNase H sequence reduces the RNase H activity below detectable levels. This product is not for sale in the United States.

Application profile Operating parameters
  • pH optimum: 9.2
  • Divalent ion requirement: Mg2+
  • Temperature optimum (for elongation): 6872C
Experimental results Figure 1: Expand High Fidelity successfully amplified the fragment from as little as 1 ng of genomic DNA. Figure 2: Consistent amplification was achieved over the full range from 1.5 mM to 5 mM Mg2+ with Expand High Fidelity. Key advantages
  • Improves fidelity of PCR amplification, because the enzyme blend amplifies with threefold greater accuracy than Taq DNA Polymerase alone
  • Produces more DNA with fewer cycles, because the proofreading activity of the enzyme blend reduces the number of truncated amplification products formed and increases the yield of full-length product
  • Saves time, because the enzyme blend requires less buffer optimization than single polymerase amplification systems and is less dependent on magnesium concentration than single polymerase PCR systems
  • Enhances results with difficult experimental systems, because the enzyme blend outperforms Taq DNA Polymerase by more accurately amplifying critical sequences (GC-rich sequences or repeat-rich sequences)
  • Ideal for multiplex PCR, because the enzyme blend produces more homogeneous fragment patterns and greater yields than Taq DNA Polymerase alone


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Expand High FidelityPLUS PCR System
2. Expand 20 kbPLUS PCR System
3. Expand Long Template PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Comparing Fidelity and Performance of Proofreading PCR Enzymes
6. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
7. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
8. High-Fidelity PCR with a Novel Polymerase Mixture
9. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
10. High Fidelity PCR Master
11. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... NY (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... do not fall low enough after prostate cancer treatment, this indicates there is still remaining ... risk of mortality. , “ The PSA test has always been an indicator of whether ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):